Article info

Download PDFPDF
Letter
Integrin a6 loss promotes colitis-associated colorectal cancer. Response to: “Integrin a6 variants and colorectal cancer” by Beaulieu JF

Authors

  • Adèle De Arcangelis Department of Development and Stem Cells, IGBMC (Institut de Génétique et de Biologie Moléculaire et Cellulaire), Université de Strasbourg, Illkirch, France Inserm, U964, Illkirch, France CNRS, UMR 7104, Illkirch, France Université de Strasbourg, Strasbourg, France PubMed articlesGoogle scholar articles
  • Mathias Chamaillard U1019 - UMR 8204 - CIIL - Centre d’Infection et d’Immunité de Lille, Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, Lille, France PubMed articlesGoogle scholar articles
  • Patricia Simon-Assmann Université de Strasbourg, Strasbourg, France MNT3 team, INSERM U1109, Strasbourg, France PubMed articlesGoogle scholar articles
  • Michel Labouesse UMR7622, IBPS, UPMC, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Adèle De Arcangelis, Department of Development and Stem Cells, IGBMC (Institut de Génétique et de Biologie Moléculaire et Cellulaire), Université de Strasbourg, Illkirch 67400, France; adele{at}igbmc.fr
View Full Text

Citation

De Arcangelis A, Chamaillard M, Simon-Assmann P, et al
Integrin a6 loss promotes colitis-associated colorectal cancer. Response to: “Integrin a6 variants and colorectal cancer” by Beaulieu JF

Publication history

  • Received November 21, 2017
  • Revised December 9, 2017
  • Accepted December 11, 2017
  • First published January 3, 2018.
Online issue publication 
November 09, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.